![]() |
市場調査レポート
商品コード
1433353
OCT(光干渉断層計)の世界市場:2023-2030年Global Optical Coherence Tomography Market 2023-2030 |
||||||
カスタマイズ可能
|
OCT(光干渉断層計)の世界市場:2023-2030年 |
出版日: 2023年12月15日
発行: Orion Market Research
ページ情報: 英文 200 Pages
納期: 2~3営業日
|
世界のOCT(光干渉断層計)市場は、予測期間(2023-2030年)にCAGR 12.2%で成長すると予測されています。OCTは、光を利用して物質や物体の断面画像を作成するイメージング技術です。音波を使って画像を作成する超音波に類似しています。OCTは非侵襲的な画像化技術であり、つまり画像化される対象物に接触する必要がないです。このため、眼の網膜のような敏感な組織を画像化するための貴重なツールとなります。
2023年10月、Altris Inc.は、同社の画像・データ管理プラットフォームであるIMSプラットフォームのFDAによる510(k)認可を発表しました。このプラットフォームは、眼科や検眼におけるOCTスキャン解析をより便利で正確なものにするため、安全なクラウド上のウェブベースアクセスを提供します。 Altris AIは5年にわたり、高度な機械学習とコンピュータビジョンアルゴリズムを用いて眼科医療専門家の臨床的意思決定をサポートするOCT判読用ソフトウェアソリューションを開発してきました。
OCTの世界市場では、用途の中でも眼科分野が大きなシェアを占めると予想されています。このセグメントの成長は、脈絡膜障害や網膜障害の発生件数の増加など、いくつかの要因に起因しており、その結果、画像診断や診断目的のために眼科医による製品採用が増加しています。例えば、2019年9月、同社のアイケア製品のラインアップを拡大するキヤノン株式会社は、キヤノン株式会社から直感的で使いやすい新しいXephilio OCT-A1OCT装置を発表しました。本装置は、自動撮影機能を搭載しており、医療従事者が簡単に使用でき、再現性の高い高品質なスキャンと画像を得ることができます。
世界のOCT市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域)、アジア太平洋地域(インド、中国、日本、韓国、その他アジア地域)、世界のその他の地域(中東とアフリカ、ラテンアメリカ)など、地域別にさらに細分化されています。なかでもアジア太平洋地域は、安全性への関心の高まり、慢性疾患の有病率の上昇、先進技術の採用の高まり、老人人口のプール、従来の方法よりも低侵襲な処置への需要の高まりなどから、世界全体で顕著な市場シェアを占めると予測されています。
全地域の中で、欧州地域は予測期間中にかなりのCAGRで成長すると予測されています。この地域の成長の背景には、研究開発投資の増加や医療認可の取得、米国医療業界における新製品の採用、病院やヘルスケア産業の拡大があります。したがって、市場プレーヤーは、市場での提携、合併、製品発売などの戦略的イニシアティブに注力しています。例えば、2021年8月、Abbott社は、同社の新しいUltreon Softwareを搭載した最新のOCTイメージングプラットフォームの米国食品医薬品局(FDA)認可を取得したと発表しました。この革新的なイメージングソフトウェアは、OCTと人工知能(AI)を組み合わせることで、冠動脈の血流と閉塞の強化された包括的なビューを医師に提供し、医師の意思決定を支援し、治療のための最良の経路を提供します。米国での承認は、最近取得したCEマークに続くもので、AIを搭載した最新技術の活用を求めるインターベンショナルカーディオロジストに、最新のOCTイメージングプラットフォームへの幅広いアクセスを提供します。Ultreon Softwareは、アボット社の新しいDragonfly OpStarイメージングカテーテルおよびPressureWire Xガイドワイヤーと統合され、医師が冠動脈血流および閉塞を評価し、患者の治療計画を改善するための幅広いツールにアクセスできるようになります。
Global Optical Coherence Tomography Market Size, Share & Trends Analysis Report by Technology (Time Domain, Frequency Domain, Spatial Encoded Frequency Domain, and Fourier Domain), by Type (Catheter-based, Doppler, Handheld, and Tabletop), and by Application (Ophthalmology, Cardiovascular, Oncology, and Others) Forecast Period (2023-2030)
The global optical coherence tomography (OCT) market is anticipated to grow at a CAGR of 12.2% during the forecast period (2023-2030). OCT is an imaging technique that uses light to create cross-sectional images of a material or object. It is analogous to ultrasound, which uses sound waves to create images. OCT is a non-invasive imaging technique, which means that it does not require any contact with the object being imaged. This makes it a valuable tool for imaging sensitive tissues, such as the retina of the eye.
In October 2023, Altris Inc. announced FDA has granted 510(k) clearance of its IMS platform, the company's image, and data management platform. the Altris platform can store, organize, and support in-depth analysis of OCT scans. The platform provides secure, on-the-cloud, web-based access to facilitate more convenient and accurate OCT scan analysis in ophthalmology and optometry. For 5 years, Altris AI has been developing software solutions for OCT interpretation to support eye care professionals in clinical decision-making using advanced machine learning and computer vision algorithms.
The global optical coherence tomography market is segmented on the technology, type, and application. based on technology, the market is sub-segmented into time domain, frequency domain, spatial encoded frequency domain and Fourier domain. based on the type, the market is sub-segmented into catheter-based, doppler, handheld and tabletop. And based on the application, the market is sub-segmented into ophthalmology, cardiovascular, oncology and others. Among the type, the handheld sub-segment is anticipated to hold a considerable share of the market, owing to its combination of microelectromechanical systems (MEMS) with 3D imaging to help in the early detection of multiple eye disorders like diabetic retinopathy, macular degeneration, and glaucoma.
Among the application, the Ophthalmology sub-segment is expected to hold a considerable share of the global Optical coherence tomography market. This segmental growth is attributed to several factor such as, the increasing incidences of choroidal and retinal disorders, which, in turn, lead to increased product adoption by ophthalmologists for imaging and diagnosing purposes. For instance, in September 2019, Expanding the company's lineup of eye-care product offerings, Canon Inc., announce the new intuitive, user-friendly Xephilio OCT-A1 Optical Coherence Tomography device from Canon Inc. This device features automated acquisition functionality, which makes it easy to use, allowing healthcare professionals to obtain high-quality reproducible scans and images. The Xephilio OCT-A1 Optical Coherence Tomography device has received FDA 510(k) clearance for sale in the United States of America1. The Xephilio OCT-A1 Optical Coherence Tomography device, together with the required RX Capture software, computer and LCD monitor.
Global optical coherence tomography market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific region is anticipated to hold a prominent share of the market across the globe, owing to rising safety concerns, rising prevalence of chronic disorders, rising adoption of advanced technologies, geriatric population pool and increasing demand for minimally invasive procedures over traditional methods in the region.
Among all regions, the European regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to increasing R&D investments and medical approvals for public use, adoption of newer products in the US medical industry and expansion of hospitals and healthcare industry. Hence, the market players are focusing on strategic initiatives such as partnership, merger, and product launch in the market. For instance, in August 2021, Abbott announced it has received US Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software. This innovative imaging software combines OCT with artificial intelligence (AI) to provide physicians an enhanced, comprehensive view of coronary blood flow and blockages to assist physician decision-making and provide the best pathway for treatment. US clearance follows the recently attained CE Mark, providing broader access to the latest OCT imaging platform for interventional cardiologists seeking to utilize the latest in AI-powered technology. Ultreon Software integrates with Abbott's new Dragonfly OpStar imaging catheter and PressureWire X guidewire to provide physicians access to a broad set of tools to assess coronary blood flow and blockages and improve treatment planning for patients.
The major companies serving the Optical coherence tomography market include Abbott Laboratories, Carl Zeiss Meditec AG, Danaher Corp, Heidelberg Engineering GmbH, Imalux Corp., Metall Zug AG, Michelson Diagnostics Ltd., NIDEK CO., LTD, Novacam Technologies, Inc., OPTOPOL Technology Sp. z o.o, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2023, Sight-saving charity Orbis has announced a new partnership with high-tech imaging solutions company Heidelberg Engineering. The company will help improve vision services by funding crucial teaching opportunities and research. Its contribution will focus on training eye care professionals around the world via Cybersight. It will also fund the charity's research into retinoblastoma, a rare cancer of the retina most commonly affecting children under the age of five. Heidelberg Engineering's contribution to Cybersight will support the delivery of live webinars on topics including optical coherence tomography (OCT), a non-invasive imaging test that uses light to capture cross-sectional scans of the back of the eye. An OCT exam can help detect serious eye conditions such as glaucoma, age-related macular degeneration, and diabetic retinopathy.